Dolby Laboratories | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 307.02 M

LB filings
2025.11.18 21:20

Revenue: As of FY2025 Q4, the actual value is USD 307.02 M, beating the estimate of USD 305.76 M.

EPS: As of FY2025 Q4, the actual value is USD 0.51, beating the estimate of USD 0.3533.

EBIT: As of FY2025 Q4, the actual value is USD 24.62 M.

Segment Revenue

  • Total Revenue: For the fourth quarter of fiscal 2025, total revenue was $307 million, compared to $305 million for the same period in fiscal 2024. For the full fiscal year 2025, total revenue was $1.35 billion, compared to $1.27 billion in fiscal 2024.

Operational Metrics

  • Net Income: GAAP net income for the fourth quarter was $49 million, or $0.51 per diluted share, compared to $59 million, or $0.61 per diluted share, in the fourth quarter of fiscal 2024. For the full year, GAAP net income was $255 million, or $2.62 per diluted share, compared to $262 million, or $2.69 per diluted share, in fiscal 2024.
  • Gross Margin: Gross profit for the fourth quarter was $267.5 million, compared to $270.8 million in the same quarter of fiscal 2024. For the full year, gross profit was $1.19 billion, compared to $1.13 billion in fiscal 2024.
  • Operating Income: Operating income for the fourth quarter was $29.7 million, compared to $46.4 million in the fourth quarter of fiscal 2024. For the full year, operating income was $265 million, compared to $258.3 million in fiscal 2024.

Cash Flow

  • Operating Cash Flow: Cash flows from operations were $472 million for the full year of fiscal 2025, compared to $327 million in fiscal 2024.

Unique Metrics

  • Licensing Revenue: Licensing revenue for the fourth quarter was $281.6 million, compared to $282.7 million in the same quarter of fiscal 2024. For the full year, licensing revenue was $1.25 billion, compared to $1.18 billion in fiscal 2024.

Outlook / Guidance

  • Revenue Guidance: For the first quarter of fiscal 2026, total revenue is estimated to range from $315 million to $345 million, with licensing revenue expected to range from $290 million to $320 million.
  • Gross Margin and Operating Expenses: Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis. Operating expenses are anticipated to range from $235 million to $245 million on a GAAP basis and from $195 million to $205 million on a non-GAAP basis.
  • Earnings Per Share: Diluted earnings per share for the first quarter of fiscal 2026 are anticipated to range from $0.39 to $0.54 on a GAAP basis and from $0.79 to $0.94 on a non-GAAP basis.
Source: LB filings The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.